FDA Approvals of Brand-Name Prescription Drugs in 2014

Ítems similars

• FDA Approvals of Brand-Name Prescription Drugs in 2015
  Publicat: (2016)
• Reporting of Drug Benefit in FDA-Approved Prescription Drug Labeling
  per: Desai, Bansri, et al.
  Publicat: (2019)
• Jakafi (Ruxolitinib): First FDA-Approved Medication for the Treatment of Patients with Polycythemia Vera
  per: Raedler, Lisa A.
  Publicat: (2015)
• New FDA Drug Approvals Hit an 18-Year High in 2014
  per: Owens, Gary M.
  Publicat: (2015)
• Jardiance (Empagliflozin), an SGLT2 Inhibitor, Receives FDA Approval for the Treatment of Patients with Type 2 Diabetes
  per: Fala, Loretta
  Publicat: (2015)